| Q53223223 | A comparison of traditional and Rasch cut points for assessing clinically important change in health-related quality of life among patients with asthma. |
| Q41572161 | A unified multi-level model approach to assessing patient responsiveness including; return to normal, minimally important differences and minimal clinically important improvement for patient reported outcome measures. |
| Q51614810 | A validated self-administered female pelvic floor questionnaire. |
| Q24244676 | Acetaminophen for osteoarthritis |
| Q24197464 | Anticonvulsants for fibromyalgia |
| Q26471557 | Antipsychotics for fibromyalgia in adults |
| Q42105861 | Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up. |
| Q44497245 | Are gait and mobility measures responsive to change following botulinum toxin injections in adults with lower limb spasticity? |
| Q58160942 | Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? |
| Q36508234 | Associations of desire for change in sexual life amongst female medical students in North America |
| Q34723964 | Asthma outcomes: quality of life |
| Q38064046 | Brief report: custom foot orthoses for foot pain: what does the evidence say? |
| Q45340788 | COPD assessment test --rationale, development, validation and performance |
| Q26472068 | Cannabinoids for chronic neuropathic pain |
| Q24188267 | Cannabinoids for fibromyalgia |
| Q26471052 | Cannabinoids for fibromyalgia |
| Q36680927 | Clinically meaningful change in stair negotiation performance in older adults |
| Q24198161 | Cognitive behavioural therapies for fibromyalgia |
| Q36219570 | Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients |
| Q50103742 | Comparing the validity and responsiveness of the EQ-5D-5L to the Oxford hip and knee scores and SF-12 in osteoarthritis patients 1 year following total joint replacement. |
| Q53168668 | Comparison of anchor-based and distributional approaches in estimating important difference in common cold. |
| Q40026261 | Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors |
| Q36235355 | Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. |
| Q24242176 | Custom-made foot orthoses for the treatment of foot pain |
| Q52013966 | Defining clinically meaningful change in health-related quality of life. |
| Q43658699 | Defining multiple criteria for meaningful outcome in routine outcome measurement using the Health of the Nation Outcome Scales |
| Q36793854 | Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis |
| Q39901255 | Determining the clinically important difference in visual analog scale scores in abuse liability studies evaluating novel opioid formulations |
| Q90657087 | Development and initial validation of the Asthma Severity Scoring System (ASSESS) |
| Q36565373 | Development and validation of patient-reported outcomes measures for overactive bladder: a review of concepts |
| Q35797092 | Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study |
| Q47656205 | Do clinical marker states improve responsiveness and construct validity of the standard gamble and feeling thermometer: a randomized multi-center trial in patients with chronic respiratory disease |
| Q40699234 | EQ-5D-derived health utilities and minimally important differences for chronic health conditions: 2011 Commonwealth Fund Survey of Sicker Adults in Canada |
| Q43701317 | Environmental risk and protective factors of adolescents' and youths' mental health: differences between parents' appraisal and self-reports. |
| Q48079746 | Epilepsy surgery and meaningful improvements in quality of life: results from a randomized controlled trial |
| Q81745377 | Estimating clinically significant differences in quality of life outcomes |
| Q30865303 | Estimating the number needed to treat from continuous outcomes in randomised controlled trials: methodological challenges and worked example using data from the UK Back Pain Exercise and Manipulation (BEAM) trial. |
| Q36471118 | Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer |
| Q44641240 | Evaluating minimal clinically important differences for the acne-specific quality of life questionnaire |
| Q55038335 | Evaluation of quality of life/life satisfaction in women with breast cancer in complementary and conventional care. |
| Q47555206 | Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review |
| Q35825918 | Health-related quality of life as an outcome variable in Parkinson's disease |
| Q48924773 | Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors |
| Q36832347 | How can quality of life researchers make their work more useful to health workers and their patients? |
| Q38071569 | ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research |
| Q48426172 | Influence of pretreatment social support on health-related quality of life in head and neck cancer survivors: results from a prospective study |
| Q79367038 | Instruments to measure acceptability of information and acquisition of knowledge in patients with heart failure |
| Q48611065 | Interpretation of Skindex-29 scores |
| Q51024230 | Interpreting change scores on the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40). |
| Q28072901 | Interpreting patient-reported outcomes from clinical trials in COPD: a discussion |
| Q35060090 | Interpreting the results of patient reported outcome measures in clinical trials: the clinician's perspective |
| Q53346876 | Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? |
| Q34761953 | Is the kidney disease quality of life-36 (KDQOL-36) a valid instrument for Chinese dialysis patients? |
| Q81745418 | Is the standard SF-12 health survey valid and equivalent for a Chinese population? |
| Q51911985 | Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. |
| Q51903168 | Measuring clinically meaningful change following mental health treatment. |
| Q38175163 | Minimal clinically important differences in pharmacological trials |
| Q36463727 | Non-specific, functional, and somatoform bodily complaints |
| Q24186403 | Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis) |
| Q30896344 | Number needed to treat (NNT): implication in rheumatology clinical practice |
| Q52014630 | On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. |
| Q33436392 | Optimizing the use of patient data to improve outcomes for patients: narcotics for chronic noncancer pain |
| Q37810773 | Patient-Reported Outcome Measures in Plastic Surgery: Use and Interpretation in Evidence-Based Medicine |
| Q35252771 | Patient-reported Outcomes for Multicentric Castleman's Disease in a Randomized, Placebo-controlled Study of Siltuximab |
| Q43548921 | People with low back pain typically need to feel 'much better' to consider intervention worthwhile: an observational study. |
| Q51929762 | Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure. |
| Q24236050 | Post-pyloric versus gastric tube feeding for preventing pneumonia and improving nutritional outcomes in critically ill adult patients |
| Q39202658 | Psychometric evaluation of a daily gastro-oesophageal reflux disease symptom measure |
| Q92258104 | Quality of Life in Palliative Care |
| Q36239338 | Quality of life in older people: a structured review of generic self-assessed health instruments |
| Q37763181 | Quality of life in older people: a structured review of self-assessed health instruments |
| Q31120497 | Reliability and validity of functional health status and health-related quality of life questionnaires in children with recurrent acute otitis media |
| Q26858781 | Responder analyses in randomised controlled trials for chronic low back pain: an overview of currently used methods |
| Q35128753 | Responsiveness and minimal clinically important difference for pain and disability instruments in low back pain patients |
| Q64245682 | Responsiveness and minimal clinically important difference of the Minnesota living with heart failure questionnaire |
| Q58395009 | Responsiveness of generic health-related quality of life measures in stroke |
| Q45998240 | Sensitivity to change in cognitive performance and mood measures of energy and fatigue in response to differing doses of caffeine or breakfast. |
| Q43239591 | Sensitivity to change in cognitive performance and mood measures of energy and fatigue in response to morning caffeine alone or in combination with carbohydrate |
| Q24201799 | Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome |
| Q52681690 | Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. |
| Q60916797 | Statistics for Evaluating Pre-post Change: Relation Between Change in the Distribution Center and Change in the Individual Scores |
| Q55605859 | Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: Prevalence, predictors, and impact on quality of life. |
| Q50201189 | Systematic review and meta-analysis of cannabinoids in palliative medicine |
| Q33269189 | The Adolescent Depression Rating Scale (ADRS): a validation study |
| Q47685367 | The MDP75: a new approach in the determination of the minimal clinically meaningful difference in a scale or a questionnaire |
| Q37978817 | The clinical importance of quality-of-life scores in patients with skull base tumors: a meta-analysis and review of the literature |
| Q36516476 | The clinical significance of quality of life assessments in oncology: a summary for clinicians |
| Q47876832 | The course of anxiety and depression for patients with Hodgkin's lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry |
| Q33536129 | The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients |
| Q37271636 | The impact of disease progression on perceived health status and quality of life of long-term cancer survivors |
| Q35226339 | The king's foot of patient-reported outcomes: current practices and new developments for the measurement of change |
| Q46836298 | The quality of life of parents of children with atopic dermatitis: interpretation of PIQoL-AD scores |
| Q53215855 | The relation between the minimally important difference and patient benefit. |
| Q55251630 | The relationship between kidney function and quality of life among community-dwelling adults varies by age and filtration marker. |
| Q37435478 | Use of both Short Musculoskeletal Function Assessment questionnaire and Short Form-36 among tibial-fracture patients was redundant |
| Q91981674 | Validation of the Brazilian version of the Shame and Stigma Scale (SSS-Br) for patients with head and neck cancers |
| Q53303888 | Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. |
| Q47676478 | WITHDRAWN: Anticonvulsants for fibromyalgia. |
| Q24796975 | What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D |
| Q86485574 | Young Mania Rating Scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort |
| Q81627029 | [Measurement of the evaluative capacity of the CVP-35 questionnaire for perceiving the quality of professional life] |